Zhang YY - Search Results

1

Novel pleuromutilin derivatives with excellent antibacterial activity against Staphylococcus aureus.

Xu P, Zhang YY, Sun YX, Liu JH, Yang B, Wang YZ, Wang YL. Xu P, et al. Among authors: zhang yy. Chem Biol Drug Des. 2009 Jun;73(6):655-60. doi: 10.1111/j.1747-0285.2009.00821.x. Chem Biol Drug Des. 2009. PMID: 19635057

2

Design, Synthesis, and Biological Activity of Thioguanine-Modified Pleuromutilin Derivatives.

Yong C, Yu J, Wu C, Zhang X, Li Y, Xie C, He X, Liu D, Wang Z, Lai P, Zhang Y. Yong C, et al. ACS Med Chem Lett. 2023 May 10;14(6):737-745. doi: 10.1021/acsmedchemlett.3c00004. eCollection 2023 Jun 8. ACS Med Chem Lett. 2023. PMID: 37312858 Free PMC article.

3

Synthesis and Biological Activities of Oxazolidinone Pleuromutilin Derivatives as a Potent Anti-MRSA Agent.

Xia J, Li Y, He C, Yong C, Wang L, Fu H, He XL, Wang ZY, Liu DF, Zhang YY. Xia J, et al. Among authors: zhang yy. ACS Infect Dis. 2023 Sep 8;9(9):1711-1729. doi: 10.1021/acsinfecdis.3c00162. Epub 2023 Aug 23. ACS Infect Dis. 2023. PMID: 37610012

4

Catalytic Asymmetric Total Synthesis of (-)-Garryine via an Enantioselective Heck Reaction.

Li C, Lu F, Cai Y, Zhang C, Shao Y, Zhang Y, Liu XY, Qin Y. Li C, et al. J Am Chem Soc. 2024 Jan 10;146(1):1081-1088. doi: 10.1021/jacs.3c12171. Epub 2023 Dec 19. J Am Chem Soc. 2024. PMID: 38113465

5

Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis.

Zhang YY, Chen EQ, Yang J, Duan YR, Tang H. Zhang YY, et al. Virol J. 2009 May 25;6:63. doi: 10.1186/1743-422X-6-63. Virol J. 2009. PMID: 19467157 Free PMC article. Review.

6

Fisetin nanoparticles based on cells cycle and apoptosis intervention for the treatment of lymphoma and leukemia.

Yang T, Gou H, Lin T, Yang Y, Jin X, Dong T, Zhang Y, Chen X. Yang T, et al. Int J Pharm. 2024 Apr 10;654:123971. doi: 10.1016/j.ijpharm.2024.123971. Epub 2024 Mar 6. Int J Pharm. 2024. PMID: 38452832

7

Design and synthesis of ERα agonists: Effectively reduce lipid accumulation.

Yang J, Yao W, Yang H, Shen Y, Zhang Y. Yang J, et al. Front Chem. 2022 Dec 8;10:1104249. doi: 10.3389/fchem.2022.1104249. eCollection 2022. Front Chem. 2022. PMID: 36569962 Free PMC article.

8

Impact of non-canonical ALK fusion on the efficacy of targeted therapy in non-small cell lung cancer.

Zeng H, Wei Q, Tang Y, Zhang Y, Tan S, Huang Q, Pu X, Li Y, Tian P. Zeng H, et al. Chin Med J (Engl). 2024 Jun 20;137(12):1468-1470. doi: 10.1097/CM9.0000000000002913. Epub 2023 Nov 29. Chin Med J (Engl). 2024. PMID: 38032041 Free PMC article. No abstract available.

9

Sensitizing chemotherapy for glioma with fisetin mediated by a microenvironment-responsive nano-drug delivery system.

Wang W, Zhang Y, Jian Y, He S, Liu J, Cheng Y, Zheng S, Qian Z, Gao X, Wang X. Wang W, et al. Nanoscale. 2023 Dec 21;16(1):97-109. doi: 10.1039/d3nr05195a. Nanoscale. 2023. PMID: 38087978

10

Development of a nanobody-horseradish peroxidase fusion-based competitive ELISA to rapidly and sensitively detect Enrofloxacin residues in animal-derived foods.

Yang M, Xu Q, Gu K, Wen R, Zhou C, Zhao Y, Guo B, Xu W, Zhang Y, Li C, Lei C, Wang H. Yang M, et al. Spectrochim Acta A Mol Biomol Spectrosc. 2024 Oct 21;327:125309. doi: 10.1016/j.saa.2024.125309. Online ahead of print. Spectrochim Acta A Mol Biomol Spectrosc. 2024. PMID: 39490174

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,205 results

Search Page

Filters